Investor Presentaiton
Economic and financial performance
| 103-2 and 103-3: Economic performance |
During the 2019/2020 crop year we
maintained our focus on the company's
financial restructuring by deleveraging
and adapting our capital structure to
the reality of the sector. Maintaining
operational discipline in the field and
industry is fundamental to facilitating
understandings with creditors,
displaying credibility and surmounting
each phase of the process.
We ended the period with net debt
of R$11,761 billion, and our cash
generation from operations stood
at around R$1,034 million, which
represents growth of 47% over the
previous crop year. During the cycle,
we attained a total net income of
R$4.5 billion, exceeding the R$4.3
billion of the previous crop year, and
an Adjusted EBITDA of R$1.5 billion.
DIRECT ECONOMIC VALUE GENERATED AND DISTRIBUTED | 201-1 |
Direct economic
2019/2020
2018/2019
2017/2018
value generated
Sales of goods, products
5,028,105
4,751,862
4,737,135
and services
Inputs acquired from
(1,825,015)
(1,987,944)
(1,821,096)
third parties
Gross value added
3,203,090
2,763,918
2,916,039
Depreciation, amortization
(1,862,591)
(1,546,767)
(1,416,442)
and depletion
Net value added
1,340,499
1,217,151
1,499,597
Value added received
160,390
147,734
100,374
in transfers
ECONOMIC AND EQUITY INDICATORS (R$ MM)
Total value added
1,500,889
1,364,885
1,599,971
to be distributed
Key indicators
2019/2020
2018/2019
2017/2018
Economic value distributed
1,500,889
1,364,885
1,599,971
Net revenues
4,549
4,281
4,243
Personnel and charges
752,224
770,376
792,861
Corporate Ebitda
1,893
1,497
1,585
Government and society
690,864
597,984
510,762
Adjusted corporate Ebitda*
1,524
1,497
1,576
(taxes, fees and contributions)
Total assets
16,690
15,144
15,810
Assignment of tax losses
(75,166)
9,857
(1,430,874)
(federal taxes)
Shareholders' equity
1,065
3,167
4,823
Creditors (interest and leases)
1,572,014
1,453,757
1,233,518
Net debt
(11,761)
(10,359)
(9,325)
Net debt/Ebitda
7.7x
6.9x
5.9x
Income (loss) for the year
(1,493,047)
(1,467,089)
479,393
Net debt/Equity
92% / 8%
77% / 23%
66% / 34%
Minority interests
14,311
* EBITDA without fair value of our biological assets, AVM of inventories and CPC 06 (IFRS 16) on farming partnerships.
40View entire presentation